Donor-specific transfusions enhance the immunosuppressive effects of single-dose cyclosporine A and CTLA4-Ig but do not result in long-term graft acceptance in a histoincompatible model of rat lung allograft rejection.
Jordan
S C
SC
Department of Pediatrics, Steven Speilberg Pediatric Research Center, Cedars-Sinai Medical Center/UCLA School of Medicine 90048, USA.
Matsumara
Y
Y
Zuo
X J
XJ
Marchevsky
A
A
Linsley
P
P
Matloff
J
J
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000627:therapeutic use*; D060908:CTLA-4 Antigen; D016572:Cyclosporine / Q000627:therapeutic use*; D004195:Disease Models, Animal; D006082:Graft Enhancement, Immunologic; D006084:Graft Rejection / Q000150:complications / Q000517:prevention & control; D006648:Histocompatibility / Q000276:immunology*; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016040:Lung Transplantation / Q000276:immunology*; D009336:Necrosis; D051381:Rats; D014657:Vasculitis / Q000150:complications
D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556708:Ctla4 protein, rat; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept; D016572:Cyclosporine